Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Solano

Showing results (251-260 of 273) with videos related to

Pageof 28
Sort By:
Bone Marrow Transplantation|March 1, 2023
SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccinationJosé Luis Piñana, Rodrigo Martino, Lourdes Vazquez, et al.
Journal of Hematology & Oncology|May 7, 2022
SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disordersJosé Luis Piñana, Lucia López-Corral, Rodrigo Martino, et al.
Transplantation and Cellular Therapy|April 15, 2021
Allogeneic Stem Cell Transplantation in Mature T Cell and Natural Killer/T Neoplasias: A Registry Study from Spanish GETH/GELTAMO CentersSilvana Novelli, Leyre Bento, Irene Garcia, et al.
Plos One|October 17, 2015
The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell TransplantationVíctor Noriega, Carolina Martínez-Laperche, Elena Buces, et al.
Cancers|June 10, 2022
Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Therapies: The GETH/GELTAMO ExperienceAntonio Gutierrez, Leyre Bento, Silvana Novelli, et al.
Frontiers in Oncology|July 17, 2024
Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapyJosé Luis Piñana, Lourdes Vazquez, Inmaculada Heras, et al.
Bone Marrow Transplantation|March 26, 2021
Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO studyLeyre Bento, Antonio Gutiérrez, Silvana Novelli, et al.
JAMA|July 10, 2019
Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical TrialAdriana Bastidas, Javier de la Serna, Mohamed El Idrissi, et al.
Transplantation and Cellular Therapy|January 14, 2026
Haploidentical Donor vs. Mismatched Unrelated Donor in Reduced-Intensity Conditioning Stem Cell Transplant, a GETH-TC StudyMaría Laura Fox, Ariadna Pérez Martínez, Albert Esquirol, et al.
Blood Cancer Journal|January 4, 2023
One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patientsJosé Luis Piñana, Lourdes Vazquez, Marisa Calabuig, et al.
Pageof 28

Showing results (251-260 of 273) with videos related to

Sort By:
Pageof 28
Bone Marrow Transplantation|March 1, 2023
SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccinationJosé Luis Piñana, Rodrigo Martino, Lourdes Vazquez, et al.
Journal of Hematology & Oncology|May 7, 2022
SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disordersJosé Luis Piñana, Lucia López-Corral, Rodrigo Martino, et al.
Transplantation and Cellular Therapy|April 15, 2021
Allogeneic Stem Cell Transplantation in Mature T Cell and Natural Killer/T Neoplasias: A Registry Study from Spanish GETH/GELTAMO CentersSilvana Novelli, Leyre Bento, Irene Garcia, et al.
Plos One|October 17, 2015
The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell TransplantationVíctor Noriega, Carolina Martínez-Laperche, Elena Buces, et al.
Cancers|June 10, 2022
Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Therapies: The GETH/GELTAMO ExperienceAntonio Gutierrez, Leyre Bento, Silvana Novelli, et al.
Frontiers in Oncology|July 17, 2024
Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapyJosé Luis Piñana, Lourdes Vazquez, Inmaculada Heras, et al.
Bone Marrow Transplantation|March 26, 2021
Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO studyLeyre Bento, Antonio Gutiérrez, Silvana Novelli, et al.
JAMA|July 10, 2019
Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical TrialAdriana Bastidas, Javier de la Serna, Mohamed El Idrissi, et al.
Transplantation and Cellular Therapy|January 14, 2026
Haploidentical Donor vs. Mismatched Unrelated Donor in Reduced-Intensity Conditioning Stem Cell Transplant, a GETH-TC StudyMaría Laura Fox, Ariadna Pérez Martínez, Albert Esquirol, et al.
Blood Cancer Journal|January 4, 2023
One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patientsJosé Luis Piñana, Lourdes Vazquez, Marisa Calabuig, et al.
Pageof 28